Insights

Sepsis is a life-threatening response of the immune system to infection that can lead to tissue damage, organ failure and the risk of permanent disability or death. Detecting and treating it early can be highly effective in stopping progression. The trouble is that implementing the level of monitoring required to catch sepsis at the earliest stages is tough outside critical care settings. 

The medical implant industry is set to grow from $5bn in 2017 to $16.3bn by 2022. But there are tensions to understand and hurdles to overcome for innovators intent on taking advantage.

Patient monitoring is an inherent part of patient management. Intermittent and continuous measurements have a range of uses, from defining disease states and characterising progression to informing therapeutic approaches and...

Technology is advancing at a remarkable pace. Can regulatory agencies keep up? They are working hard at that and in that process come many changes. The line between what is a consumer device and what is a...

Fresh from an in-person visit to BioData World Conference 2021, Andrew Goulter discusses the role big pharma is playing in unlocking a complex new healthcare ecosystem. His hope? That effective data sharing and democratised access will deliver advantages for healthcare professionals and patients alike… 
 

Cambridge Consultants Harshal Shah, head of oncology innovations for global medical technology presents on how miniature active implants are key area for innovation in next-generation drug delivery.

Medtech Connect | Beyond COVID-19 - investigating and innovating for the next generation 

People with diabetes have an increased risk of developing serious health problems, including neuropathy. We’ve developed an AI-based system, in partnership with eminent specialists, to assess the presence of neuropathy from retinal images.

The International Pharmaceutical Aerosol Consortium on Regulation & Science (IPAC-RS) is launching a Roundtable webinar series on digital devices for 2021. Presented by subject matter experts in the pharmaceutical sciences, this is a unique opportunity to learn about the latest research and regulatory trends focused on digital devices.

Is now the time for AI and digital tech to revolutionise the whole field of pathology? Andrew Goulter, VP, Life Sciences at Cambridge Consultants certainly thinks so, as he explains here. 

Joe Corrigan, Head of Intelligent Healthcare, joined a panel of experts at MWC 2021 to share recent breakthroughs which have used AI to disrupt the healthcare industry and save lives.

Regulatory approval for ophthalmic combination products is like gold dust. The final instalment in our ophthalmology series walks you through the challenges and helps plot a route to market.